80
16
Growth Score
-8 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
482148
DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease.
- Johannes Holzmeister: Chairman & CEO
- Valeria Ricotti: EVP & Chief Medical Officer
About the Company
DiNAQOR is a gene therapy platform company that focuses on advancing novel solutions for patients suffering from heart disease. The company's novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure. Its lead
preclinical program, DiNA-001, is focused on the treatment of MYBPC3-linked cardiomyopathy.
DiNAQOR was founded in 2019 and is headquartered in Pfäffikon, Switzerland.
